L-Arginine Reduces Heart Collagen Accumulation in the Diabetic db/db Mouse
Background Diabetic cardiomyopathy presents with significant collagen accumulation; decreased solubility, increased glucose-mediated abnormal cross-linking, free radical crosslinking, or glucose-induced increased transcription of collagen is incriminated. In a previous study, we reduced collagen accumulation in the kidneys of diabetic mice by treatment with oral arginine. This observation led us to examine the effect of arginine on cardial fibrosis. Methods and Results Twenty-nine db/db spontaneously diabetic mice were used in the experiments. Sixteen were given L-arginine (free base, in tap water, 50 mg/kg body wt per day) for 4 months. At the end of the experiment, we determined total collagen content of total ventricular tissue, acid solubility, carboxymethyllysine, O-tyrosine, glutathione, blood glucose, and fructosamine as parameters for glycemic control. Heart collagen level was significantly (P=.0001) reduced in the experimental group (mean, 0.24±0.05) compared with the control group (mean, 0.49±0.10 ,mol hydroxyproline per 100 mg heart tissue). Significantly more collagen could be eluted from heart samples of the experimental group (P=.02). Carboxymethyllysine and O-tyrosine did not differ when related to heart weight. Glutathione level was significantly higher in the untreated group (P=.003). Parameters of glycemic control did not differ between the groups.
Conclusions Our findings clearly indicate that L-arginine reduced total heart collagen and increased acid solubility of heart collagen. Both findings are compatible with the cross-linking hypothesis. The data for carboxymethyllysine, O-tyrosine, and glutathione would rule out the glycoxidation hypothesis and, therefore, free radical cross-linking. The postulated mechanism of action is most likely the blocking of reactive carbonyl functions by L-arguiine in analogy to aminoguanidine activity. Correlations of collagen with glycemic control, however, point to an association of glucose with collagen metabolism, a phenomenon docu-M yocardial fibrosis is a main feature of diabetic cardiomyopathy. The mechanisms leading to collagen accumulation, however, are not fully elucidated. Several factors have been incriminated, but nonenzymatic glycosylation is a major pathogenetic factor for connective tissue changes in the diabetic state. Advanced-stage nonenzymatic glycosylation products (AGEs) are known to lead to increased abnormal glucose-mediated cross-linking of collagen and other connective tissue proteins.1 Reactive carbonyl species (eg, deoxyglucosone or methylglyoxal) are reactive aldehydes mediating cross-linking through reaction with free amino groups of proteins. According to other modern concepts, glycoxidation appears to be the underlying chemical process for collagen accumulation and long-term diabetic complications.2 Glycoxidation is the free radical-mediated oxidation of glycosylated proteins with AGEs (eg, N-epsilon-carboxymethyllysine3).
Previously, we reported the reduction of kidney collagen accumulation by L-arginine in the db/db mouse model for diabetes.4 Based on this observation, we used L-arginine for the experimental reduction of heart collagen.
Methods Animals
Twenty-nine db/db mice (Shaw's Farm) were used in the experiment (Fig 1) . The db/db mice used in the study have diabetes that resembles type 2 adult-onset diabetes in humans. During the first months of life, these animals are hyperphagic and rapidly become obese. The initial metabolic abnormality is hyperinsulinemia, which persists until 4 to 5 months when degenerative changes in the islets also occur.5 Severe hyperglycemia occurs along with severe glycosuria between weeks 6 and 8.6 Collagen accumulation increases steadily between 5 weeks and 4 months.7 Treatment was started at the age of 3 months.
All animals had free access to mouse ration (Altromin), and the control group also had free access to tap water. The experimental group (n=16) was given 50 mg L-arginine PO (free base, per kg body wt per day) for 4 months.
Body weight and food and fluid uptake did not differ statistically between the groups at the start of the experiment and at death. The animals were maintained at a day/night rhythm at 23°C. At the end of the experiment, animals were killed by neck dislocation, and necropsies were performed. The hearts (total ventricular tissue) were taken for biochemical investigations.
All experiments were conducted in accordance with the guiding principles of the American Physiological Society.
Determination of Total Ventricular Hydroxyproline
For determination of total heart hydroxyproline, aliquots of total ventricular tissue were weighed and hydrolyzed with 6 N HCl at 105°C for 16 hours. Hydrolyzed tissue was evaporated on a Pierce reactitherm and redissolved in distilled water.
After centrifugation to remove insoluble material, the samples were analyzed for presence of 4-trans-hydroxyproline by the method of Woessner.8 For determination of eluted heart hydroxyproline, heart collagen was eluted to obtain information on collagen solubility, which in turn provides evidence of collagen cross-linking. Aliquots of heart tissue were homogenized and eluted by pepsin (1 mg/100 mg heart tissue) in 0.05 mol/L acetic acid containing 0.005 mol/L EDTA for 72 hours at 25°C. The eluate was hydrolyzed, evaporated, and redissolved as described above. This solution was also subject to analysis by Woessner's method.
Determination of Total Ventricular Collagen
Aliquots of ventricular tissue were homogenized by a Potter in an ice bath in a solution used for collagen elution as described above, incubated for 72 hours at 25°C, and spun down in a centrifuge at 4°C at 400Qg. The supernatant was used for the Sircol collagen assay (Sircol Collagen Assay Kit, Oubis Ltd) and sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE).
The principle of the Sircol collagen assay is the binding of a dye to collagen. The collagen-bound dye is recovered by centrifugation, eluted with alkali, and measured using a spectrophotometer at 540 nm. The intensity of color measurement is proportional to the collagen concentration in a sample.
SDS-PAGE
Collagen extracted from total ventricular tissue was characterized on SDS-PAGE following the principle of Limmli.9 This method provides semiquantitative information about collagen degradation products.
Determination of N-Epsilon-carboxymethyllysine
N-Epsilon-carboxymethyllysine was determined in tissue hydrolyzates as previously determined'0 and expressed as N-epsilon-carboxymethyllysine per 100 mg of heart tissue or as N-epsilon-carboxymethyllysine per hydroxyproline. Briefly, samples were derivatized with O-phthalaldehyde and run on high-performance liquid chromatography using a gradient system. A typical chromatogram is given in Fig 2. 
Determination of O-Tyrosine
O-Tyrosine was determined in heart hydrolyzates by highperformance liquid chromatography as determined previously. 11 
Determination of Glutathione
Glutathione was determined in pepsin eluates (extracts) as described above and assayed following the enzymatic method of Anderson12 using a commercially available kit (GSH 400, Bioxytech). Serum glucose was determined following a glucose oxidase standard method on a Greiner autoanalyzer. Serum fructosamine was determined using a commercially available spectrophotometric method (fructosamine kit, Hoffmann La Roche).
Statistical Analysis
Mann-Whitney U test for comparison of the groups and the linear regression coefficient r were used in evaluating the results. '3 Results
The determination of total heart hydroxyproline expressed in micromoles per 100 mg of heart tissue reflecting collagen accumulation revealed significantly higher concentrations in the untreated group (P=.0001), as described in Table 1 .
In determination of eluted heart collagen, as shown in Table 1 , no significant differences in amount of collagen eluted from heart tissue could be detected (P=.62). If, however, the ratios of eluted to total collagen were calculated, significantly more collagen could be extracted from treated heart (P=.02).
As shown in Table 1 , total ventricular collagen was significantly (P<.01) reduced in the treated group. On SDS-PAGE, no collagen split products could be Table 1 presents the outcome of glutathione determirevealed, and no different patterns were observed in the nations indicating significantly higher levels in the ungroups studied. treated panel (P=.003). The results of carboxymethyllysine per 100 mg of As listed in Table 1 , neither serum fructosamine heart weight and carboxymethyllysine related to colla-(P=.60) nor serum glucose (P=.70) differed signifigen content are listed in Table 1 . Comparison of the cantly between the groups. groups showed no significant difference in carboxymeth-.c s yllysine per 100 mg of heart weight (P=.24). The results Discussion expressed as carboxymethyllysine related to collagen As shown in "Results," L-arginine treatment for 4 contents, however, clearly indicated significantly higher months significantly reduced collagen accumulation in ratios in the treated group (P=.0003).
total ventricular tissue of spontaneously diabetic mice. As shown in Table 1 , no difference between O-tyro-We propose that the mechanism of action is the inhibisine in the treated group and in the untreated group tion of glucose-mediated collagen cross-links4 through could be evaluated in expressing O-tyrosine per 100 mg blockade of reactive carbonyl species. Our findings of heart tissue (P=.36). When O-tyrosine was expressed as increased solubility of collagen in the hearts of treated related to collagen contents, a significantly higher 0-tymice support this hypothesis as collagen solubility is a rosine content was found in the treated group (P=.03). reliable marker for cross-linking. The possibility that differences in glycemic control may have led to differences in the collagen content was ruled out by comparable serum fructosamine levels. In testing the current concept of glycoxidation as a pathogenetic mechanism, we determined parameters for the involvement of free oxygen radicals, ie, carboxymethyllysine, O-tyrosine, and glutathione. In contrast to studies on diabetic kidneys in db/db mice showing decreased kidney carboxymethyllysine after arginine treatment, we could not find any differences in heart carboxymethyllysine when expressed as carboxymethyllysine per heart weight. Correlating carboxymethyllysine per weight with the ratio of eluted to total collagen showed a significant positive correlation (in the untreated group only), ruling out free radical cross-linking. This finding is confirmed by an increased ratio of carboxymethyllysine to hydroxyproline in the treated group.
O-Tyrosine, a parameter for free hydroxyl radical attack," failed to differ between the groups if expressed as O-tyrosine per 100 mg of heart weight. In addition, no significant correlation to collagen content or eluted collagen was found, ruling out a role of hydroxyl attack in the postulated oxidative stress in diabetes mellitus and free radical cross-linking of collagen as the cause of collagen accumulation. When O-tyrosine was related to total hydroxyproline content, the unexpected result of higher values in the treated group was found. No correlation was found with total collagen content, eluted collagen, or ratio of eluted to total collagen. In the glutathione-system heart, glutathione was significantly higher in the untreated panel. This again is further evidence against the oxidative stress hypothesis.
Glutathione is a potent free oxygen radical scavenger and would be expected to be higher in the treated animals, where oxidative stress compounds and intermediates should have already been blocked by arginine therapy. One explanation could be that the sulfhydryl residues responsible for scavenging of free oxygen radicals are less reactive with aldehydes abundant in the diabetic system than reactive guanidino and amino groups of L-arginine free base. No correlation of glutathione with total collagen, eluted collagen, or ratio of eluted to total collagen was observed. Three parameters for oxidative stress did not indicate that glycoxidation is responsible for collagen accumulation in the diabetic heart. The findings also postulate that L-arginine, which clearly reduced heart collagen in our study and led to increased solubility and therefore reduced abnormal collagen cross-linking, did not act by scavenging free oxygen radicals but rather by blocking carbonyl residues of reactive aldehydes as cross-linking aldehydes from collagen lysines and deoxyglucosones as reactive species observed in diabetes.14 Major organ differences (in terms of free oxygen radical handling by superoxide dismutase, glutathionemetabolizing enzymes, and other redox systems) between heart and kidney, where N-epsilon-carboxymethyllysine correlation with collagen reduction was described, also could be responsible for our findings.
The fact that free oxygen radical parameters showed oxidative stress in the treated group rather than in the untreated group could be explained by the effect of nitric oxide formation from arginine in the endothelium.15 Nitric oxide from arginine, however, could not have been involved in free radical cross-linking because the increased solubility by arginine treatment clearly showed decreased cross-linking. At present, nothing is known about collagen turnover in the presence of nitric oxide.
Recent publications described in vitro evidence of the direct role of glucose in collagen synthesis. Using molecular biological methods in cell cultures, authors described increased mRNA for procollagen by glucose in a dose-dependent manner. 16 We found no difference in glucose serum concentrations between the groups, no significant correlation between glucose and total heart collagen, but a significant correlation between glucose levels and eluted collagen in the arginine-treated group. No significant correlation of glucose and the quotient of ratio of eluted to total heart collagen was found, but there was a trend toward correlation. In testing longterm integrated glucose values as expressed by levels of serum fructosamine, we found no differences between the groups, but serum fructosamine turned out to be significantly and impressively correlated with total heart collagen in the treated panel. Collagens are the major extracellular matrix proteins, making up approximately 80%. Collagen types and their relevance in diabetic cardiomyopathy were described recently. In addition to an increase in collagen types I and III, the switch and increase of collagen type VI can be observed.'7 Collagen accumulation or myocardial fibrosis is an unequivocal consistent finding in diabetic cardiomyopathy,18-21 although it is not known whether increased collagen synthesis or decreased catabolism by increased glucosemediated abnormal cross-linking (expressed by decreased solubility) is the underlying cause. Both increased synthesis and abnormally cross-linked collagen could be responsible for the observed increase in stiffness of the myocardial tissue.
Arginine led to increased solubility and therefore decreased cross-linking by a mechanism described for arginine and aminoguanidine on kidney collagen.1 '4,22 Other mechanisms also could have been active; arginine is known to release insulin, but this mechanism is highly improbable as no differences were detected in fructosamine. Another mechanism could have been responsible as it is well documented that arginine stimulates macrophage activities23 and that macrophages present receptors for AGEs on their surfaces,24 an indicator that AGEs could have been cleared from tissues and/or circulation. Because arginine is known to activate interleukin-la and this cytokine induces collagenase activity, increased collagenolysis also could have been involved. 25 Our findings on SDS-PAGE did not show the presence of collagen split products, and therefore the mechanism of increased collagenolysis is highly improbable. We successfully reduced collagen accumulation in the diabetic heart, but it remains to show whether this finding has functional benefits.
